Rapt Therapeutics, Inc. (RAPT)

57.57 +22.47 (+64.02%) USD  |  NASDAQ  |  Jan 20, 16:00
57.59 +0.02 (+0.03%) After-Hours: 07:30
More

Rapt Therapeutics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade